Haranath Parepally

1.7k total citations
24 papers, 1.2k citations indexed

About

Haranath Parepally is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Haranath Parepally has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 8 papers in Clinical Psychology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Haranath Parepally's work include Schizophrenia research and treatment (17 papers), Bipolar Disorder and Treatment (11 papers) and Electroconvulsive Therapy Studies (8 papers). Haranath Parepally is often cited by papers focused on Schizophrenia research and treatment (17 papers), Bipolar Disorder and Treatment (11 papers) and Electroconvulsive Therapy Studies (8 papers). Haranath Parepally collaborates with scholars based in United States, United Kingdom and Israel. Haranath Parepally's co-authors include K. N. Roy Chengappa, Jaspreet S. Brar, Joseph Levine, Richard F. Ulrich, Mary Carter, S. Flesher, Gerard E. Hogarty, Deborah P. Greenwald, Michael F. Pogue‐Geile and KN Roy Chengappa and has published in prestigious journals such as Biological Psychiatry, Schizophrenia Research and The Journal of Clinical Psychiatry.

In The Last Decade

Haranath Parepally

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haranath Parepally United States 16 986 320 204 141 133 24 1.2k
Luchezar Hranov Israel 9 1.1k 1.1× 319 1.0× 275 1.3× 200 1.4× 132 1.0× 17 1.3k
Halldóra Jónsdóttir Norway 19 1.3k 1.3× 304 0.9× 217 1.1× 173 1.2× 174 1.3× 24 1.6k
Maria A. Rettenbacher Austria 21 963 1.0× 339 1.1× 214 1.0× 287 2.0× 210 1.6× 54 1.5k
Stephen M. Erhart United States 8 802 0.8× 232 0.7× 191 0.9× 172 1.2× 184 1.4× 8 1.0k
Astrid B. Birkenaes Norway 20 1.4k 1.4× 318 1.0× 224 1.1× 186 1.3× 182 1.4× 23 1.9k
Siow‐Ann Chong Singapore 23 795 0.8× 201 0.6× 164 0.8× 82 0.6× 48 0.4× 43 1.1k
René S. Kahn Netherlands 5 805 0.8× 180 0.6× 193 0.9× 96 0.7× 67 0.5× 8 1.1k
John Abel Engh Norway 20 1.3k 1.3× 303 0.9× 226 1.1× 219 1.6× 192 1.4× 35 1.8k
V.P. Kontaxakis Greece 21 640 0.6× 317 1.0× 113 0.6× 102 0.7× 141 1.1× 73 1.2k
Marta Rapado‐Castro Spain 21 857 0.9× 340 1.1× 126 0.6× 286 2.0× 98 0.7× 53 1.3k

Countries citing papers authored by Haranath Parepally

Since Specialization
Citations

This map shows the geographic impact of Haranath Parepally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haranath Parepally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haranath Parepally more than expected).

Fields of papers citing papers by Haranath Parepally

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haranath Parepally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haranath Parepally. The network helps show where Haranath Parepally may publish in the future.

Co-authorship network of co-authors of Haranath Parepally

This figure shows the co-authorship network connecting the top 25 collaborators of Haranath Parepally. A scholar is included among the top collaborators of Haranath Parepally based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haranath Parepally. Haranath Parepally is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schooler, Nina R., Stephen R. Marder, K. N. Roy Chengappa, et al.. (2016). Clozapine and Risperidone in Moderately Refractory Schizophrenia. The Journal of Clinical Psychiatry. 77(5). 628–634. 13 indexed citations
2.
Brar, Jaspreet S., et al.. (2008). The Impact of Olanzapine on Tardive Dyskinetic Symptoms in a State Hospital Population. Annals of Clinical Psychiatry. 20(3). 139–144. 8 indexed citations
3.
Chengappa, KN Roy, David J. Kupfer, Haranath Parepally, et al.. (2007). A placebo‐controlled, random‐assignment, parallel‐group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type. Bipolar Disorders. 9(6). 609–617. 24 indexed citations
4.
Brar, Jaspreet S., KN Roy Chengappa, Vineeth John, et al.. (2004). The prevalence of the metabolic syndrome in patients with schizoaffective disorder – bipolar subtype. Bipolar Disorders. 6(4). 314–318. 113 indexed citations
5.
Sarkar, Sonali, et al.. (2004). Leukopenia in clozapine treated patients may be induced by other drugs: a case series. European Psychiatry. 19(8). 506–509. 20 indexed citations
6.
Hogarty, Gerard E., S. Flesher, Richard F. Ulrich, et al.. (2004). Cognitive Enhancement Therapy for Schizophrenia. Archives of General Psychiatry. 61(9). 866–866. 378 indexed citations
7.
Schooler, N., S.R. Marder, John M. Kane, et al.. (2003). Clozapine and risperidone in moderately refractory schizophrenia: A six month double-blind comparison. Schizophrenia Research. 60(1). 302–302. 1 indexed citations
8.
Parepally, Haranath, et al.. (2003). Attitudes towards taking Medicine among those patients who either received Olanzapine or First Generation Antipsychotic Agents.. PubMed. 45(3). 151–4. 1 indexed citations
9.
Parepally, Haranath, et al.. (2002). The use of concomitant medications in psychiatric inpatients treated with either olanzapine or other antipsychotic agents. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 26(3). 437–440. 15 indexed citations
10.
Chengappa, K. N. Roy, et al.. (2002). Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: An open-label, nonrandomized chart review. Clinical Therapeutics. 24(10). 1576–1584. 95 indexed citations
11.
Chengappa, K. N. Roy, et al.. (2001). Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series. European Psychiatry. 16(3). 186–190. 62 indexed citations
12.
Chengappa, K. N. Roy, et al.. (2001). Olanzapine Use in Subjects with Pervasive Developmental Disorder Displaying Aggression and/or Self-Mutilation. Journal of Psychiatric Practice. 7(3). 156–156. 1 indexed citations
13.
Levine, Joseph, K. N. Roy Chengappa, Anthony H. Vagnucci, et al.. (2001). Obesity and Medical Illnesses in Psychiatric Patients Admitted to a Long-term Psychiatric Facility. Journal of Psychiatric Practice. 7(6). 432–439. 18 indexed citations
14.
Chengappa, K. N. Roy, et al.. (2000). Anticholinergic Differences Among Patients Receiving Standard Clinical Doses of Olanzapine or Clozapine. Journal of Clinical Psychopharmacology. 20(3). 311–316. 57 indexed citations
15.
Chengappa, KN Roy, et al.. (2000). Impact of Risperidone on Seclusion and Restraint at a State Psychiatric Hospital. The Canadian Journal of Psychiatry. 45(9). 827–832. 29 indexed citations
16.
Chengappa, KN Roy, et al.. (1999). Topiramate as add‐on treatment for patients with bipolar mania. Bipolar Disorders. 1(1). 42–53. 117 indexed citations
17.
Chengappa, K. N. Roy, et al.. (1999). Clozapine Reduces Severe Self-Mutilation and Aggression in Psychotic Patients With Borderline Personality Disorder. The Journal of Clinical Psychiatry. 60(7). 477–484. 104 indexed citations
18.
Chengappa, K. N. Roy, Jaspreet S. Brar, Haranath Parepally, et al.. (1999). Risperidone Use at a State Hospital. The Journal of Clinical Psychiatry. 60(6). 373–378. 17 indexed citations
19.
Ahmed, Shakeel, et al.. (1998). Clozapine Withdrawal_Emergent Dystonias and Dyskinesias. The Journal of Clinical Psychiatry. 59(9). 472–477. 75 indexed citations
20.
Brar, Jaspreet S., et al.. (1997). The effects of clozapine on negative symptoms in patients with schizophrenia with minimal positive symptoms.. Annals of Clinical Psychiatry. 9(4). 227–234. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luchezar Hranov Breakdown of academic impact, for papers by Halldóra Jónsdóttir Breakdown of academic impact, for papers by Maria A. Rettenbacher Breakdown of academic impact, for papers by Stephen M. Erhart Breakdown of academic impact, for papers by Astrid B. Birkenaes Breakdown of academic impact, for papers by Siow‐Ann Chong Breakdown of academic impact, for papers by René S. Kahn Breakdown of academic impact, for papers by John Abel Engh Breakdown of academic impact, for papers by V.P. Kontaxakis Breakdown of academic impact, for papers by Marta Rapado‐Castro
Rankless by CCL
2026